No, Eyetalk is a licensee of REVO. Eyetalk was created solely for the purpose of facilitating our lawsuits, commercializing the patents, and acquiring licensees. In return Eyetalk gets 60%.. well I should probably say REVO gets 40% from Eyetalk BIG difference
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.